What are the uses and dosages of Acetazolamide (carbonic anhydrase inhibitor) in various medical conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acetazolamide: Uses and Dosages in Various Medical Conditions

Acetazolamide is a versatile carbonic anhydrase inhibitor used for multiple medical conditions with specific dosing regimens ranging from 125-1000 mg daily depending on the indication, with effectiveness demonstrated for glaucoma, epilepsy, altitude sickness, edema, and idiopathic intracranial hypertension. 1

Primary Indications and Dosages

Glaucoma

  • Dosage: 250 mg to 1 g daily, usually in divided doses for amounts over 250 mg 2
  • Used as adjunctive therapy to usual glaucoma treatments
  • For secondary glaucoma and preoperative treatment of acute congestive (closed-angle) glaucoma: 250 mg every four hours 2
  • Some acute cases may respond better to an initial dose of 500 mg followed by 125-250 mg every four hours 2
  • The American Academy of Ophthalmology supports these dosing recommendations 1

Epilepsy

  • Dosage: 8-30 mg/kg daily in divided doses 2
  • Optimum range: 375-1000 mg daily 2
  • When adding to existing anticonvulsants: Start with 250 mg once daily 2
  • Most effective for petit mal seizures in children, but also beneficial for grand mal, mixed seizure patterns, and myoclonic jerk patterns 2
  • Transition from other medications should be gradual 2

Altitude Sickness

  • Dosage: 125-250 mg twice daily, starting 24 hours before ascent 1
  • Reduces risk of acute mountain sickness by 48% compared to placebo 3
  • Lower dose of 62.5 mg twice daily has been shown to be non-inferior to 125 mg twice daily in prevention 4
  • Improves nocturnal oxygenation at high altitudes 1

Congestive Heart Failure

  • Dosage: 250-375 mg once daily in the morning (5 mg/kg) 2
  • Most effective when given on alternate days or for two days alternating with a day of rest 2
  • Does not eliminate need for other therapy such as digitalis, bed rest, and salt restriction 2

Drug-Induced Edema

  • Dosage: 250-375 mg once daily for one or two days, alternating with a day of rest 2

Off-Label Uses

Obstructive Sleep Apnea

  • The European Respiratory Society suggests use only in the context of clinical trials 5
  • Can reduce sleep apnea intensity by up to 45% 5
  • Improves nocturnal oxygenation, especially at high altitudes 5
  • Not approved for OSA treatment 5

Idiopathic Intracranial Hypertension

  • Reduces cerebrospinal fluid production and intracranial pressure 6
  • Can help avoid invasive procedures in patients with CSF leaks or elevated ICP 6

Other Uses

  • Ventilator weaning for COPD patients 6
  • Prevention of high-dose methotrexate toxicity 6
  • Prevention of contrast-induced nephropathy 6

Contraindications and Precautions

  • Contraindicated in:

    • Sulfonamide allergy 1
    • Severe hepatic disease 1
    • Severe renal disease 1
    • Adrenocortical insufficiency 1
    • Hyperchloremic acidosis 1
    • Kidney stones 5
    • Aplastic anemia 5
    • Sickle cell disease 5
  • Dosage adjustment:

    • For creatinine clearance <50 mL/min, do not administer more frequently than every 12 hours 6

Adverse Effects

  • Common side effects:

    • Paresthesias 5, 1
    • Vertigo 5, 1
    • Altered taste 1
    • Allergic dermatitis/conjunctivitis 5
    • Malaise, anorexia, depression 5
  • Serious side effects:

    • Kidney stones 5, 7
    • Metabolic acidosis 5, 7
    • Blood dyscrasias (aplastic anemia, thrombocytopenia) 5
    • Stevens-Johnson syndrome 5
    • Serum electrolyte imbalances 5

Monitoring Recommendations

  • Monitor serum electrolytes, particularly for hypokalemia 1
  • Monitor renal function 1
  • Monitor acid-base status 1
  • Watch for signs of dehydration, especially when combined with other diuretics 1
  • Avoid combining with other diuretics due to increased risk of dehydration and electrolyte imbalances 1

Clinical Pearls

  • Acetazolamide's pharmacologic effects last longer than its 4-8 hour plasma half-life 6
  • For altitude sickness, proper acclimatization remains essential (gradual ascent of 300-600m/day above 2500m) 1
  • Immediate descent is the primary treatment for severe altitude illness, regardless of medication use 1
  • Side effects appear to be dose-related, suggesting that using the lowest effective dose may improve tolerability 4
  • When used for epilepsy, partial tolerance may develop to the antiepileptic activity 7

References

Guideline

Acetazolamide Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluating off-label uses of acetazolamide.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2018

Research

Acetazolamide in the treatment of seizures.

The Annals of pharmacotherapy, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.